Quantcast

Latest DelMar Pharmaceuticals Inc. Stories

2014-11-17 08:30:19

Data Presented at the 19th Annual Society for Neuro-Oncology Meeting Demonstrate VAL-083 Superiority to Temozolomide in Key Preclinical Models VANCOUVER, British Columbia, MENLO PARK, Calif.,

2014-11-14 12:25:46

VAL-083 Anti-tumor Activity Is Consistently Superior to Temozolomide in Preclinical Models of Glioblastoma VANCOUVER, British Columbia, MENLO PARK, Calif., and MIAMI, Nov.

2014-11-10 08:32:56

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov.

2014-10-09 08:27:59

DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.

2014-10-06 12:29:21

VANCOUVER, British Columbia and MENLO PARK, Calif., Oct.

2014-09-04 08:30:32

VANCOUVER, British Columbia and MENLO PARK, Calif., Sept.

2014-09-03 08:33:48

-- Brings Total Number of DelMar's Patents Covering VAL-083 to Two U.S. Patents and One International Patent -- VANCOUVER, British Columbia and MENLO PARK, Calif., Sept.

2014-08-29 08:24:27

Investor update call to be held Tuesday, September 2 VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.

2014-08-27 16:25:38

DelMar Is Advancing Clinical Trials With VAL-083 As A New Chemotherapy For Refractory Glioblastoma Multiforme VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.

2014-08-19 08:29:50

VAL-083 Phase I/II VAL-083 clinical trial advances to 50mg/m(2) cohort VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.


Word of the Day
marcescent
  • Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.
Related